JD Bos

European S3‐Guidelines on the systemic treatment of psoriasis vulgaris

Delano Pathirana, AD Ormerod, P. Saïag et al. · Journal of the European Academy of Dermatology and Venereology · 2009 · 695 citations · Full text

Treatment of vitiligo vulgaris with narrow‐band UVB and oral <i>Polypodium leucotomos</i> extract: a randomized double‐blind placebo‐controlled study

M.A. Middelkamp‐Hup, JD Bos, Francisca Ríus et al. · Journal of the European Academy of Dermatology and Venereology · 2007 · 161 citations

Soluble interleukin-2 receptor (sIL-2R) is a marker of disease activity in psoriasis: a comparison of sIL-2R, sCD27, sCD4, sCD8 and sICAM-1.

Menno A. de Rie, IM Zonneveld, Leonard Witkamp et al. · Acta Dermato Venereologica · 1996 · 41 citations · Full text

Ultrastructural findings in progressive macular hypomelanosis indicate decreased melanin production

GN Relyveld, KP Dingemans, HE Menke et al. · Journal of the European Academy of Dermatology and Venereology · 2008 · 36 citations

Long-term Treatment with 0.1% Tacrolimus Ointment in Adults with Atopic Dermatitis: Results of a Two-year, Multicentre, Non-comparative Study

Sakari Reitamo, Ortonne Jp, Carsten Sand et al. · Acta Dermato Venereologica · 2007 · 33 citations · Full text

Drug Hypersensitivity, Skin Burning, Allergy +10